Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Heather G. Ahlgren"'
Autor:
Mirai Mizutani, Julie Bérubé, Heather G. Ahlgren, Joanie Bernier, Elias Matouk, Dao Nguyen, Simon Rousseau
Publikováno v:
ERJ Open Research, Vol 3, Iss 2 (2017)
Decreasing the inflammatory response that leads to tissue damage during cystic fibrosis (CF) lung disease has been a long-standing goal of CF therapy. While corticosteroids are widely used anti-inflammatory drugs, their efficacy in CF lung disease re
Externí odkaz:
https://doaj.org/article/3d08e2874c4640539b17042f8802e077
Autor:
Simon Rousseau, Heather G. Ahlgren, Elias Matouk, Joanie Bernier, Dao Nguyen, Mirai Mizutani, Julie Bérubé
Publikováno v:
ERJ Open Research, Vol 3, Iss 2 (2017)
Decreasing the inflammatory response that leads to tissue damage during cystic fibrosis (CF) lung disease has been a long-standing goal of CF therapy. While corticosteroids are widely used anti-inflammatory drugs, their efficacy in CF lung disease re
Publikováno v:
Journal of Bacteriology. 195:2011-2020
Pseudomonas aeruginosa , a human opportunistic pathogen, possesses a number of antioxidant defense enzymes under the control of multiple regulatory systems. We recently reported that inactivation of the P. aeruginosa stringent response (SR), a starva
Autor:
Mirai, Mizutani, Julie, Bérubé, Heather G, Ahlgren, Joanie, Bernier, Elias, Matouk, Dao, Nguyen, Simon, Rousseau
Publikováno v:
ERJ Open Research
Decreasing the inflammatory response that leads to tissue damage during cystic fibrosis (CF) lung disease has been a long-standing goal of CF therapy. While corticosteroids are widely used anti-inflammatory drugs, their efficacy in CF lung disease re
Autor:
Elias Matouk, Dao Nguyen, Larry C. Lands, Andrea Benedetti, Simon Rousseau, Danuta Radzioch, Jennifer S. Landry, Joanie Bernier, James Gruber, Heather G. Ahlgren, Gabriella Wojewodka
Publikováno v:
Journal of pulmonary & respiratory medicine
Introduction: In stable adult cystic fibrosis (CF) patients, we assessed the role of baseline high sensitivity C-reactive protein (hs-CRP) on CF clinical variables and frequency of intravenous (IV) treated pulmonary exacerbations (PExs) 1-year post-
Autor:
Simon Rousseau, Jennifer S. Landry, Andrea Benedetti, Dao Nguyen, Joanie Bernier, Danuta Radzioch, Larry C. Lands, Elias Matouk, Heather G. Ahlgren
Publikováno v:
BMC Pulmonary Medicine
Background Staphylococcus aureus (SA) is the most prevalent organism infecting the respiratory tract of CF children, and remains the second most prevalent organism in CF adults. During early childhood, SA infections are associated with pulmonary infl
Autor:
James Schafhauser, Geoffrey McKay, Dao Nguyen, François Lépine, Malika Khakimova, Heather G. Ahlgren
Publikováno v:
Journal of Bacteriology
Journal of Bacteriology, American Society for Microbiology, 2014, 96 (9), pp.1641-1650. ⟨10.1128/JB.01086-13⟩
Journal of Bacteriology, American Society for Microbiology, 2014, 96 (9), pp.1641-1650. ⟨10.1128/JB.01086-13⟩
As a ubiquitous environmental organism and an important human pathogen, Pseudomonas aeruginosa readily adapts and responds to a wide range of conditions and habitats. The intricate regulatory networks that link quorum sensing and other global regulat
Autor:
Juan B. De Sanctis, Gabriella Wojewodka, Jim Gruber, Dao Nguyen, Elias Matouk, Larry C. Lands, Heather G. Ahlgren, Julie Bérubé, Simon Rousseau, Jennifer S. Landry, Andrea Benedetti, Joanie Bernier, Danuta Radzioch
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e88567 (2014)
PLoS ONE, Vol 9, Iss 2, p e88567 (2014)
Introduction Pulmonary exacerbations (PEs) cause significant morbidity and can severely impact disease progression in cystic fibrosis (CF) lung disease, especially in patients who suffer from recurrent PEs. The assessments able to predict a future PE
Autor:
Gabriella Wojewodka, Juan B De Sanctis, Joanie Bernier, Julie Bérubé, Heather G Ahlgren, Jim Gruber, Jennifer Landry, Larry C Lands, Dao Nguyen, Simon Rousseau, Andrea Benedetti, Elias Matouk, Danuta Radzioch
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88567 (2014)
Pulmonary exacerbations (PEs) cause significant morbidity and can severely impact disease progression in cystic fibrosis (CF) lung disease, especially in patients who suffer from recurrent PEs. The assessments able to predict a future PE or a recurre
Externí odkaz:
https://doaj.org/article/2793943f2127415e8008b604a02cb010